Literature DB >> 29441281

Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners.

Kelly A Brown1, Sharmeen Samuel1, Dilip R Patel1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.

Entities:  

Keywords:  Attention-deficit/hyperactivity disorder (ADHD); alpha-2-agonists; amphetamine; methylphenidate; non-stimulant medication; stimulants

Year:  2018        PMID： 29441281      PMCID： PMC5803014          DOI： 10.21037/tp.2017.08.02

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


  29 in total

1.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

2.  ADHD drugs and cardiovascular risk.

Authors:  Steven E Nissen
Journal:  N Engl J Med       Date:  2006-03-20       Impact factor: 91.245

3.  Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.

Authors:  Robert L Findling; Joseph Biederman; Timothy E Wilens; Thomas J Spencer; James J McGough; Frank A Lopez; Simon J Tulloch
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

Review 4.  Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects.

Authors:  Mark D Rapport; Catherine Moffitt
Journal:  Clin Psychol Rev       Date:  2002-11

5.  ADHD drugs and serious cardiovascular events in children and young adults.

Authors:  William O Cooper; Laurel A Habel; Colin M Sox; K Arnold Chan; Patrick G Arbogast; T Craig Cheetham; Katherine T Murray; Virginia P Quinn; C Michael Stein; S Todd Callahan; Bruce H Fireman; Frank A Fish; Howard S Kirshner; Anne O'Duffy; Frederick A Connell; Wayne A Ray
Journal:  N Engl J Med       Date:  2011-11-01       Impact factor: 91.245

6.  Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.

Authors:  Rakesh Jain; Scott Segal; Scott H Kollins; Moise Khayrallah
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-02       Impact factor: 8.829

Review 7.  Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.

Authors:  Rakesh Jain; Alain Katic
Journal:  Prim Care Companion CNS Disord       Date:  2016-08-18

8.  Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.

Authors:  Victoria L Vetter; Josephine Elia; Christopher Erickson; Stuart Berger; Nathan Blum; Karen Uzark; Catherine L Webb
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

Review 9.  The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.

Authors:  Victoria A Reed; Jan K Buitelaar; Ernie Anand; Kathleen Ann Day; Tamás Treuer; Himanshu P Upadhyaya; David R Coghill; Ludmila A Kryzhanovskaya; Nicola C Savill
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

10.  Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy.

Authors:  Shivanand Kattimani; S Mahadevan
Journal:  Ann Indian Acad Neurol       Date:  2011-01       Impact factor: 1.383
View more
  10 in total

Review 1.  Current Pharmacological Treatments for ADHD.

Authors:  Madeleine J Groom; Samuele Cortese
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial.

Authors:  Abbas Ali Sangouni; Hamid Mirhosseini; Mahdieh Hosseinzadeh
Journal:  Trials       Date:  2022-10-22       Impact factor: 2.728

Review 3.  Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.

Authors:  Zsolt Kovács; Dominic P D'Agostino; David Diamond; Mark S Kindy; Christopher Rogers; Csilla Ari
Journal:  Front Psychiatry       Date:  2019-05-23       Impact factor: 4.157

Review 4.  Fragile X Syndrome: From Molecular Aspect to Clinical Treatment.

Authors:  Dragana D Protic; Ramkumar Aishworiya; Maria Jimena Salcedo-Arellano; Si Jie Tang; Jelena Milisavljevic; Filip Mitrovic; Randi J Hagerman; Dejan B Budimirovic
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

5.  Experiences of neurofeedback therapists in treating attention-deficit hyperactivity disorder.

Authors:  Jessica Oliveira; Janice Pellow; Tebogo Tsele-Tebakang; Elizabeth M Solomon
Journal:  Health SA       Date:  2022-07-28

Review 6.  Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.

Authors:  Valerie Tourjman; Gill Louis-Nascan; Ghalib Ahmed; Anaïs DuBow; Hubert Côté; Nadia Daly; George Daoud; Stacey Espinet; Joan Flood; Emilie Gagnier-Marandola; Martin Gignac; Gemma Graziosi; Zeeshan Mansuri; Joseph Sadek
Journal:  Brain Sci       Date:  2022-08-01

7.  Sleep-disordered breathing and genetic findings in children with Prader-Willi syndrome in China.

Authors:  Aizhen Lu; Feihong Luo; Chengjun Sun; Xiaobo Zhang; Libo Wang; Wei Lu
Journal:  Ann Transl Med       Date:  2020-08

8.  Executive Function and Attention Performance in Children with ADHD: Effects of Medication and Comparison with Typically Developing Children.

Authors:  Martina Miklós; Judit Futó; Dániel Komáromy; Judit Balázs
Journal:  Int J Environ Res Public Health       Date:  2019-10-10       Impact factor: 3.390

Review 9.  ADHD: Reviewing the Causes and Evaluating Solutions.

Authors:  Luis Núñez-Jaramillo; Andrea Herrera-Solís; Wendy Verónica Herrera-Morales
Journal:  J Pers Med       Date:  2021-03-01

Review 10.  Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions.

Authors:  Christian Popow; Susanne Ohmann; Paul Plener
Journal:  Neuropsychiatr       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.